<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39331173</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-1588</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz</Title><ISOAbbreviation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz</ISOAbbreviation></Journal><ArticleTitle>[Fatigue after COVID-19 disease associated with depression and anxiety in insured persons from healthcare and social professions].</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00103-024-03953-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Fatigue is one of the most frequent symptoms in post-COVID syndrome (PCS) patients and describes a long-term feeling of tiredness and exhaustion. Frequently, it follows an infection or is a component of depressive symptoms. But fatigue itself is also a risk to mental health like other chronic conditions. The objective of this paper was to analyse the relationship between fatigue and depression/anxiety and the differences between PCS patients and fully recovered COVID-19 cases.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a longitudinal study with three measurement points, insured members of the Statutory Accident Insurance and Prevention in the Health and Welfare Service with a SARS-CoV‑2 infection in 2020 were asked about fatigue, depression/anxiety and persisting COVID-19 symptoms. To analyse the longitudinal effects of the two variables, a cross-lagged panel model was applied.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the present sample (n = 860), a proportion of 68.7% to 75.1% of people was suffering from PCS. The results showed a model fit of R<sup>2</sup> = 61.49% and all effects were significant, but the cross-lagged effects were not significantly different from each other. If stratified according to whether PCS symptoms were present, the cross-lagged effects weakened in both groups, while the effects of fatigue on depression and anxiety only remained in the group of those affected by PCS.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The results show a relationship in both directions between fatigue and depression/anxiety. PCS patients can benefit from psychotherapeutic treatment to tackle fatigue and prevent depression and anxiety.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mertens</LastName><ForeName>Svenja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut und Poliklinik für Medizinische Psychologie, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland. s.mertens@uke.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nienhaus</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch-Gromus</LastName><ForeName>Uwe</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Institut und Poliklinik für Medizinische Psychologie, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Fatigue nach einer COVID-19-Erkrankung im Zusammenhang mit Depressivität und Ängstlichkeit bei Versicherten aus Gesundheits- und Sozialberufen.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz</MedlineTA><NlmUniqueID>101181368</NlmUniqueID><ISSNLinking>1436-9990</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="ZUSAMMENFASSUNG" NlmCategory="UNASSIGNED">HINTERGRUND: Fatigue bezeichnet einen andauernden Erschöpfungszustand, der auf eine Infektionskrankheit folgen kann. Sie zählt zu den häufigsten Symptomen beim Post-Covid-Syndrom (PCS). Auch bei psychischen Erkrankungen kann Fatigue auftreten, allerdings ist Fatigue, wie andere chronische Erkrankungen, auch selbst ein Risikofaktor für Depressivität und Ängstlichkeit. Ziel der Analyse ist es, zu untersuchen, inwieweit sich Fatigue und Depressivität/Ängstlichkeit gegenseitig bedingen und ob es Unterschiede zwischen PCS-Betroffenen und vollständig Genesenen gibt.</AbstractText><AbstractText Label="METHODIK" NlmCategory="METHODS">In einer Längsschnittuntersuchung mit 3 Messzeitpunkten wurden Versicherte der Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege, die im Jahr 2020 mit SARS-CoV‑2 infiziert waren, zu Fatigue, Depressivität/Ängstlichkeit und lang anhaltenden COVID-19-Symptomen befragt. Zur Analyse der längsschnittlichen Effekte der beiden Variablen wurde ein kreuzlagiges Paneldatenmodell angewandt.</AbstractText><AbstractText Label="ERGEBNISSE" NlmCategory="UNASSIGNED">Die Stichprobe (n = 860) weist zu den 3 Messzeitpunkten einen Anteil von 68,7–75,1 % an PCS-Betroffenen auf. Das Modell zeigt eine Güte von R<sup>2</sup> = 61,49 % und durchgehend signifikante Effekte, jedoch unterscheiden sich die kreuzlagigen Pfade nicht signifikant voneinander. Wird danach stratifiziert, ob eine PCS-Symptomatik vorliegt, schwächen sich in beiden Gruppen die kreuzlagigen Effekte ab, während nur in der Gruppe der PCS-Betroffenen die Effekte von Fatigue auf Depressivität und Ängstlichkeit bestehen bleiben.</AbstractText><AbstractText Label="DISKUSSION" NlmCategory="CONCLUSIONS">Die vorliegenden Ergebnisse zeigen einen wechselseitigen Zusammenhang von Fatigue- und Depressivitäts‑/Ängstlichkeitssymptomatik. PCS-Betroffene könnten von psychotherapeutischen Behandlungen aufgrund ihrer Fatigue profitieren, da dem Entstehen von Depressionen oder Angststörungen vorgebeugt werden kann.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Healthcare workers</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">Post-viral fatigue</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39331173</ArticleId><ArticleId IdType="doi">10.1007/s00103-024-03953-y</ArticleId><ArticleId IdType="pii">10.1007/s00103-024-03953-y</ArticleId></ArticleIdList><ReferenceList><Title>Literatur</Title><Reference><Citation>World Health Organization (2024) Number of COVID-19 cases reported to WHO (cumulative total): World. https://data.who.int/dashboards/covid19/cases . Zugegriffen: 27. Aug. 2024</Citation></Reference><Reference><Citation>Robert Koch-Institut (2023) Wöchentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19): 08.06.2023 – Aktualisierter Stand für Deutschland. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2023-06-08.pdf?__blob=publicationFile . Zugegriffen: 26. Mai 2024</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22:e102–e107. https://doi.org/10.1016/s1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(21)00703-9</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U et al (2024) S1-Leitlinie Long‑/Post-COVID (Stand: 30.05.2024). Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP). https://register.awmf.org/assets/guidelines/020-027l_S1_Long-Post-Covid_2024-06_1.pdf . Zugegriffen: 16. Juli 2024</Citation></Reference><Reference><Citation>Nalbandian A, Desai AD, Wan EY (2023) Post-COVID-19 Condition. Annu Rev Med 74:55–64. https://doi.org/10.1146/annurev-med-043021-030635</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-030635</ArticleId><ArticleId IdType="pubmed">35914765</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B (2022) Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis 226:1593–1607. https://doi.org/10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 11:16144. https://doi.org/10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId><ArticleId IdType="pmc">8352980</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J et al (2022) Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci 434:120162. https://doi.org/10.1016/j.jns.2022.120162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId><ArticleId IdType="pmc">8798975</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL et al (2011) Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med 270:327–338. https://doi.org/10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId><ArticleId IdType="pmc">3427890</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton EW (2015) Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA 313:1101–1102</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.1346</ArticleId><ArticleId IdType="pubmed">25668027</ArticleId></ArticleIdList></Reference><Reference><Citation>Grach SL, Seltzer J, Chon TY, Ganesh R (2023) Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 98:1544–1551. https://doi.org/10.1016/j.mayocp.2023.07.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2023.07.032</ArticleId><ArticleId IdType="pubmed">37793728</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJean D, Giacomini M, Vanstone M, Brundisini F (2013) Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser 13:1–33</Citation><ArticleIdList><ArticleId IdType="pubmed">24228080</ArticleId><ArticleId IdType="pmc">3817950</ArticleId></ArticleIdList></Reference><Reference><Citation>König RS, Paris DH, Sollberger M, Tschopp R (2024) Identifying the mental health burden in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients in Switzerland: A pilot study. Heliyon 10:e27031. https://doi.org/10.1016/j.heliyon.2024.e27031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2024.e27031</ArticleId><ArticleId IdType="pubmed">38434357</ArticleId><ArticleId IdType="pmc">10907781</ArticleId></ArticleIdList></Reference><Reference><Citation>Müller K, Zwingmann K, Auerswald T et al (2021) Rehabilitation and Return-to-Work of Patients Acquiring COVID-19 in the Workplace: A Study Protocol for an Observational Cohort Study. Front Rehabil Sci 2:754468. https://doi.org/10.3389/fresc.2021.754468</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fresc.2021.754468</ArticleId><ArticleId IdType="pubmed">36188830</ArticleId></ArticleIdList></Reference><Reference><Citation>Müller K, Poppele I, Ottiger M et al (2023) Impact of Rehabilitation on Physical and Neuropsychological Health of Patients Who Acquired COVID-19 in the Workplace. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph20021468</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021468</ArticleId><ArticleId IdType="pubmed">38248486</ArticleId><ArticleId IdType="pmc">10815598</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutsch M, Frommhold J, Buhr-Schinner H, Gross T, Schüller PO, Deck R (2023) Pneumological Rehabilitation in Patients with Long Covid—Health Changes at the End of the Inpatient Rehabilitation Measure. Rehabilitation 62:359–368. https://doi.org/10.1055/a-1964-7401</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1964-7401</ArticleId><ArticleId IdType="pubmed">36649730</ArticleId></ArticleIdList></Reference><Reference><Citation>Décary S, De Groote W, Arienti C et al (2022) Scoping review of rehabilitation care models for post COVID-19 condition. Bull World Health Organ 100:676–688. https://doi.org/10.2471/blt.22.288105</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/blt.22.288105</ArticleId><ArticleId IdType="pubmed">36324552</ArticleId><ArticleId IdType="pmc">9589389</ArticleId></ArticleIdList></Reference><Reference><Citation>Wachtler B, Neuhauser H, Haller S et al (2021) The Risk of Infection with SARS-CoV‑2 Among Healthcare Workers During the Pandemic. Dtsch Ärztebl Int 118:842–843. https://doi.org/10.3238/arztebl.m2021.0376</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2021.0376</ArticleId><ArticleId IdType="pubmed">35264284</ArticleId><ArticleId IdType="pmc">8941660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferland L, Carvalho C, Gomes DJ et al (2022) Risk of hospitalization and death for healthcare workers with COVID-19 in nine European countries, January 2020–January 2021. J Hosp Infect 119:170–174. https://doi.org/10.1016/j.jhin.2021.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2021.10.015</ArticleId><ArticleId IdType="pubmed">34752802</ArticleId><ArticleId IdType="pmc">8665668</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller J, Kocalevent R‑D, Nienhaus A, Peters C, Bergelt C, Koch-Gromus U (2022) Anhaltende Fatigue als Folge einer COVID-19-Infektion bei Beschäftigten im Gesundheitswesen: Risikofaktoren und Auswirkungen auf die Lebensqualität. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65:471–480. https://doi.org/10.1007/s00103-022-03511-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-022-03511-4</ArticleId><ArticleId IdType="pubmed">35298664</ArticleId><ArticleId IdType="pmc">8928711</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakel RE (1999) Depression. Prim Care 26:211–224. https://doi.org/10.1016/S0095-4543(08)70003-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0095-4543(08)70003-4</ArticleId><ArticleId IdType="pubmed">10318745</ArticleId></ArticleIdList></Reference><Reference><Citation>Smets EMA, Garssen B, Bonke B, De Haes JCJM (1995) The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325. https://doi.org/10.1016/0022-3999(94)00125-O</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(94)00125-O</ArticleId><ArticleId IdType="pubmed">7636775</ArticleId></ArticleIdList></Reference><Reference><Citation>Binz C, Osmanovic A, Thomas NH et al (2022) Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy. Ann Clin Transl Neurol 9:351–362. https://doi.org/10.1002/acn3.51520</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51520</ArticleId><ArticleId IdType="pubmed">35191616</ArticleId><ArticleId IdType="pmc">8935281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajek A, König HH (2020) Prevalence and Correlates of Individuals Screening Positive for Depression and Anxiety on the PHQ‑4 in the German General Population: Findings from the Nationally Representative German Socio-Economic Panel (GSOEP). Int J Environ Res Public Health. https://doi.org/10.3390/ijerph17217865</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17217865</ArticleId><ArticleId IdType="pubmed">33327486</ArticleId><ArticleId IdType="pmc">7764965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazlauskas E, Gelezelyte O, Kvedaraite M et al (2023) Psychometric properties of the Patient Health Questionnaire‑4 (PHQ-4) in 9230 adults across seven European countries: Findings from the ESTSS ADJUST study. J Affect Disord 335:18–23. https://doi.org/10.1016/j.jad.2023.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2023.05.007</ArticleId><ArticleId IdType="pubmed">37164064</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinders H (2006) Kausalanalysen in der Längsschnittforschung. Das Cross-Lagged-Panel Design. J Child Adolesc Res 1:569–587</Citation></Reference><Reference><Citation>Orth U, Meier LL, Bühler JL et al (2024) Effect size guidelines for cross-lagged effects. Psychol Methods 29:421–433. https://doi.org/10.1037/met0000499</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/met0000499</ArticleId><ArticleId IdType="pubmed">35737548</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>